With over a decade of expertise as a seasoned synthetic organic chemist, I have navigated the realms of both industry and academia. My academic journey includes earning a Ph.D. in Organic Chemistry from the University of Calcutta, where I delved into pioneering directing group mediated C-H activation reactions using transition metal catalysts. Notably, I developed a novel biologically relevant directing group, enabling diverse C-H activated transformations on amide derivatives. My research outcomes has been published in esteemed journals. Transitioning into the dynamic realm of industry, I have amassed over a decade of experience in the contract research organization (CRO) sector. Collaborating with leading pharmaceutical companies globally, I have played an integral role in medicinal chemistry research. Although my industry contributions haven't manifested in published papers, they have significantly impacted collaborative projects and contributed to advancements in the field. Complementing my academic background, I conducted a two-year post-doctoral research stint at Ajou University, Suwon, South Korea, focusing on the synthesis and development of small molecule fluorescent dyes for biosensing applications that resulted high impact publication in peer reviewed journal. Currently, as a Research Associate at Rensselaer Polytechnic Institute, New York, USA, I continue to leverage my academic research insights to inform and enhance my contributions to drug discovery. My research focuses on the intersection of synthetic organic chemistry and drug development, particularly in areas such as ophthalmic indications, COVID-19, and neuropathic pain, with a specific emphasis on Glycine Transporter 2 (GlyT2) Inhibitors. I bring a unique blend of academic rigor and industry acumen, making me well-equipped for collaborative ventures in medicinal chemistry, organic synthesis, and drug discovery. Connect with me for engaging discussions and potential collaborations at the intersection of academia and industry.